Germany Menopause Market Size & Outlook, 2022-2030
Germany menopause market, 2018-2030 (US$M)
Related Markets
Germany menopause market highlights
- The Germany menopause market generated a revenue of USD 495.1 million in 2022 and is expected to reach USD 739.5 million by 2030.
- The Germany market is expected to grow at a CAGR of 5.1% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 495.1 million |
| Market revenue in 2030 | USD 739.5 million |
| Growth rate | 5.1% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, Germany accounted for 3.1% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.
Dietary supplements was the largest segment with a revenue share of 93.9% in 2022. Horizon Databook has segmented the Germany menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
In Germany, dietary supplements are scrutinized for efficacy and safety by Commission E, a part of the German Federal Institute for Drugs and Medical Devices. Commission E has approved black cohosh (the brand Remifemin), 40 mg/day for six months for dysmenorrhea, Premenstrual Syndrome (PMS), and menopausal symptoms. Increasing awareness about the use of dietary supplements in easing menopause symptoms, along with the availability of approved dietary supplements, can positively impact market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany menopause market size, by treatment, 2018-2030 (US$M)
Germany Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
